Skip to main content
. 2024 Feb 20;326(5):L524–L538. doi: 10.1152/ajplung.00283.2023

Table 1.

Details about the source of the proteins used in this study

Protein Concentration Source Reference Number Provider
recSP-A1 20 µM Recombinant, prokaryotic expressed OPCD07130 Aviva Bio Systems
recSP-A2 20 µM Recombinant, prokaryotic expressed OPCD07132 Aviva Bio Systems
rhSP-D 7.44 µM Recombinant, CHO cells (eukaryotic, mammal) AT-100 Airway Therapeutics
hSP-A 6.5 µM Human PAP patient, BAL isolated
hSP-D 0.6 µM Human PAP patient, BAL isolated